Method of labeling proteins with technetium
OwnerJean Abramovici, Andre Marie Ermans +1inventors
InventorsJean Abramovici, Andre Marie Ermans, Omer Jeghers
Life of this patent
Estimating the term…
Abstract
Fibrinogen is labeled with .sup.99m Technetium by reducing pertechnetate at a pH of about 11-12 using a solution of stannous chloride in the presence of a base, then contacting the reduced pertechnetate with fibrinogen. Unwanted lower molecular weight impurities are removed; the labeled product suitably adjusted to a pH of 7-8 to form an injectable isotopic tracer solution.
Claims18
A method of labeling fibrinogen with 99m technetium comprising reducing pertechnetate at a pH of about 11 to 12 by the addition of a solution of acetic acid and stannous chloride in the presence of a base, contacting the thus reduced pertechnetate with fibrinogen thereby labeling the fibrinogen with 99m technetium and purifying the resulting mixture by removing unwanted degradation products of the fibrinogen and non-bound technetium.
A method of binding 99m technetium to fibrinogen to produce fibrinogen labeled with 99m technetium comprising the steps of:
- 1. reducing pertechnetate at a pH of about 11 to 12 by the addition thereto of a solution of acetic acid and stannous chloride in the presence of a base;
- 2. contacting the thus reduced pertechnetate with fibrinogen thereby labeling the fibrinogen with 99m technetium;
- 3. removing unbound technetium and technetium bound to molecules having a molecular weight less than 100,000, and in a second purification step;
- 4. removing all molecules having a molecular weight less than 300,000, thereby producing a product having about 90% or more of the 99m technetium bound to the fibrinogen.
A method of producing an injectable solution of 99m technetium labeled fibrinogen comprising the steps of:
- 1. reducing pertechnetate at a pH of about 11-12 by adding a solution of acetic acid and stannous chloride in the presence of a base;
- 2. dissolving lyophilized fibrinogen including buffer salts associated therewith in water yielding a fibrinogen solution;
- 3. mixing the fibrinogen solution of step (2) with the reduced pertechnetate of step (1) at ambient temperature for about 15 minutes;
- 4. lowering the pH of the solution of step (3) to a final pH of about 7-8 by the addition of an aqueous solution of sodium citrate and citric acid;
- and
- 5. removing fibrinogen degradation products and non-bound technetium, thereby producing an injectable solution of fibrinogen labeled with 99m technetium.
Dependencies are inferred from the claim text.